Ontario restricts new rental building in favour of Sanofi pharma plant
  •  —
  • Mar 14, 2026

Ontario restricts new rental building in favour of Sanofi pharma plant

  • The Globe and Mail
Major changes to cardiovascular guidelines suggest taking statins as young as 30
  • Mar 14, 2026

Major changes to cardiovascular guidelines suggest taking statins as young as 30

  • STAT
FDA approves use of RSV vaccine in at-risk younger adults
  • Mar 14, 2026

FDA approves use of RSV vaccine in at-risk younger adults

  • CIDRAP
Xenon stock soars as B.C. drug developer reports strong results for epilepsy treatment
  •  —
  • Mar 13, 2026

Xenon stock soars as B.C. drug developer reports strong results for epilepsy treatment

  • The Globe and Mail
Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds
  • Mar 11, 2026

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

  • The Guardian
Ottawa should prioritize reviews and procurement of Canadian-made drugs, manufacturers say
  •  —
  • Mar 11, 2026

Ottawa should prioritize reviews and procurement of Canadian-made drugs, manufacturers say

  • The Globe and Mail
FDA warns Novo Nordisk of potential unreported GLP-1 side effects
  • Mar 11, 2026

FDA warns Novo Nordisk of potential unreported GLP-1 side effects

  • NBC News
U.S. FDA says it met with states interested in importing cheaper drugs from Canada
  •  —
  • Mar 10, 2026

U.S. FDA says it met with states interested in importing cheaper drugs from Canada

  • The Globe and Mail
Trump admin looks to boost biosimilars to lower drug costs
  •  —
  • Mar 10, 2026

Trump admin looks to boost biosimilars to lower drug costs

  • Axios
Can a "Living Drug" Cure Autoimmune Diseases?
  •  —
  • Mar 09, 2026

Can a "Living Drug" Cure Autoimmune Diseases?

  • The New Yorker
Regina researchers seek new antibiotic treatments that could save lives
  •  —
  • Mar 09, 2026

Regina researchers seek new antibiotic treatments that could save lives

  • Regina Leader-Post
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
  • Mar 09, 2026

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration

  • Associated Press
Anti-obesity treatment could cost as little as $3 per month
  • Mar 09, 2026

Anti-obesity treatment could cost as little as $3 per month

  • Canadian Affairs
Canada-U.S. Trade Minister and federal Health Minister meet with pharma sector as Trump doubles down on cutting U.S. drug prices
  •  —
  • Mar 08, 2026

Canada-U.S. Trade Minister and federal Health Minister meet with pharma sector as Trump doubles down on cutting U.S. drug prices

  • The Hill Times
  • Mar 07, 2026

Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract

  • CISION
Weight-loss jab could be made for $3 a month, study finds
  • Mar 06, 2026

Weight-loss jab could be made for $3 a month, study finds

  • The Guardian
U.S. FDA approves J&J's blood cancer drug after speedy review
  • Mar 06, 2026

U.S. FDA approves J&J's blood cancer drug after speedy review

  • Reuters
Vaccine for Bacterial Diarrhea Successful in Human Trials
  • Mar 06, 2026

Vaccine for Bacterial Diarrhea Successful in Human Trials
China approves pfizer's glp-1 drug for weight management
  • Mar 06, 2026

China approves pfizer's glp-1 drug for weight management

  • Reuters
Fragile X diagnosis propelled our family into advocacy and drug discovery
  • Mar 05, 2026

Fragile X diagnosis propelled our family into advocacy and drug discovery

  • Patient Voice
  •  — 
  • Nick Parr
Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds
  • Mar 04, 2026

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

  • The Guardian
Top FDA drug official is trying to hire a friend who's seeking to put pregnancy warnings on antidepressants
  • Mar 04, 2026

Top FDA drug official is trying to hire a friend who's seeking to put pregnancy warnings on antidepressants

  • Associated Press
Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds
  •  —
  • Mar 04, 2026

Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds

  • The New York Times
3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits
  • Mar 04, 2026

3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits

  • CBC News
RNA vaccine funding cuts threaten decades of scientific progress
  • Mar 04, 2026

RNA vaccine funding cuts threaten decades of scientific progress

  • CIDRAP
US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs
  • Mar 03, 2026

US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs

  • Reuters
3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests
  • Mar 03, 2026

3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests

  • CTV News
Health Canada approves Ozempic to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes
  • Mar 02, 2026

Health Canada approves Ozempic to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes

  • CISION
Researchers praise 'stunning' results of new prostate cancer treatment
  • Feb 28, 2026

Researchers praise 'stunning' results of new prostate cancer treatment

  • The Guardian
Quarterly Financial Report for the Quarter Ended December 31, 2025: Patented Medicine Prices Review Board
  • Feb 28, 2026

Quarterly Financial Report for the Quarter Ended December 31, 2025: Patented Medicine Prices Review Board

  • Government of Canada
European regulators recommend approval of combined mRNA vaccine for flu and COVID
  • Feb 27, 2026

European regulators recommend approval of combined mRNA vaccine for flu and COVID

  • CIDRAP
Could weight-loss drugs prevent cancer? How about vaccines? What's behind Canada's historic bet on prevention science
  • Feb 27, 2026

Could weight-loss drugs prevent cancer? How about vaccines? What's behind Canada's historic bet on prevention science

  • Toronto Star
FDA to offer bonus payments to staffers who complete speedy drug reviews
  • Feb 27, 2026

FDA to offer bonus payments to staffers who complete speedy drug reviews

  • Associated Press
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
  • Feb 26, 2026

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

  • Reuters
Novavax raises revenue forecast on boost from vaccine deals, shares soar
  • Feb 26, 2026

Novavax raises revenue forecast on boost from vaccine deals, shares soar

  • Reuters
B.C. teen first in world to be cured of rare disease through gene editing treatment
  • Feb 26, 2026

B.C. teen first in world to be cured of rare disease through gene editing treatment

  • Vancouver Sun
Study to examine whether Ozempic can reduce the risk of blood cancer
  •  —
  • Feb 26, 2026

Study to examine whether Ozempic can reduce the risk of blood cancer

  • The Globe and Mail
New GLP-1 pill helped trial patients lose up to 8% of body weight
  • Feb 26, 2026

New GLP-1 pill helped trial patients lose up to 8% of body weight

  • The Guardian
FDA says a plausible mechanism can be enough for rare disease approval : NPR
  • Feb 23, 2026

FDA says a plausible mechanism can be enough for rare disease approval : NPR
An approved new treatment slows the progress of Alzheimer's — but will provincial drug plans offer it?
  • Feb 22, 2026

An approved new treatment slows the progress of Alzheimer's — but will provincial drug plans offer it?

  • Toronto Star
  • Feb 21, 2026

The Health Minister said much last week

  • CHW Insights
  •  — 
  • Nick Tsergas
Grail shares plummet after UK study raises doubts over cancer test's prospects
  • Feb 20, 2026

Grail shares plummet after UK study raises doubts over cancer test's prospects

  • Reuters

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing